Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 02 06 2018
accepted: 05 03 2019
entrez: 5 4 2019
pubmed: 5 4 2019
medline: 1 1 2020
Statut: epublish

Résumé

The genital tract of African women has been shown to differ from what is currently accepted as 'normal', defined by a pH≤4.5 and lactobacilli-dominated microbiota. Adolescent girls and young women (AGYW) from sub-Saharan Africa are at high risk for HIV, and we hypothesized that specific biological factors are likely to be influential. This study aimed to compare characteristics of vaginal health in HIV-negative AGYW (16-22-years-old), from two South African communities, to international norms. We measured plasma hormones, vaginal pH, presence of BV (Nugent scoring), sexually transmitted infections (multiplex PCR for Chlamydia trachomatis, Neisseria gonorrhoea, Trichomonas vaginalis, Mycoplasma genitalium) and candidiasis (Gram stain) in AGYW (n = 298) from Cape Town and Soweto. Cervicovaginal microbiota was determined by 16S pyrosequencing; 44 genital cytokines were measured by Luminex; and cervical T-cell activation/proliferation (CCR5, HLA-DR, CD38, Ki67) was measured by multiparametric flow cytometry. 90/298 (30.2%) AGYW were negative for BV, candidiasis and bacterial STIs. L. crispatus and L. iners were the dominant bacteria in cervicovaginal swabs, and the median vaginal pH was 4.7. AGYW with L. crispatus-dominant microbiota (42.4%) generally had the lowest cytokine concentrations compared to women with more diverse microbiota (34/44 significantly upregulated cytokines). Frequencies of CCR5+CD4+ T-cells co-expressing CD38 and HLA-DR correlated positively with interleukin (IL)-6, TNF-α, GRO-α, macrophage inflammatory protein (MIP)-1α, and IL-9. While endogenous oestrogen had an immune-dampening effect on IL-6, TNF-related apoptosis-inducing ligand (TRAIL) and IL-16, injectable hormone contraceptives (DMPA and Net-EN) were associated with significantly lower endogenous hormone concentrations (p<0.0001 for oestrogen and progesterone) and upregulation of 34/44 cytokines. Since genital inflammation and the presence of activated CD4+ T cells in the genital tract have been implicated in increased HIV risk in South African women, the observed high levels of genital cellular activation and cytokines from AGYW may point towards biological factors increasing HIV risk in this region.

Identifiants

pubmed: 30947260
doi: 10.1371/journal.pone.0213975
pii: PONE-D-18-16541
pmc: PMC6448899
doi:

Substances chimiques

Cytokines 0
Estrogens 0
Progesterone 4G7DS2Q64Y

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0213975

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Mucosal Immunol. 2016 Jan;9(1):194-205
pubmed: 26104913
Microbiology. 2014 Oct;160(Pt 10):2272-2282
pubmed: 25073854
J Fam Plann Reprod Health Care. 2006 Apr;32(2):104-6
pubmed: 16824301
AIDS Res Hum Retroviruses. 2008 Jul;24(7):973-6
pubmed: 18671479
AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1149-1158
pubmed: 27726428
Clin Infect Dis. 2015 Jul 15;61(2):260-9
pubmed: 25900168
Am J Obstet Gynecol. 1999 Nov;181(5 Pt 1):1263-9
pubmed: 10561657
Eur Cytokine Netw. 1998 Dec;9(4):687-8
pubmed: 9889416
Mucosal Immunol. 2017 Nov;10(6):1480-1490
pubmed: 28401934
PLoS Med. 2015 Jan 22;12(1):e1001778
pubmed: 25612136
AIDS. 2010 Aug 24;24(13):2069-74
pubmed: 20588163
J Int AIDS Soc. 2015 Feb 26;18(2 Suppl 1):19408
pubmed: 25724504
J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):318-325
pubmed: 28187085
Sex Transm Dis. 2015 Jul;42(7):358-63
pubmed: 26222747
J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):1-7
pubmed: 26761267
Sex Transm Dis. 2012 Nov;39(11):880-5
pubmed: 23064538
J Clin Invest. 1998 Feb 15;101(4):746-54
pubmed: 9466968
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
J Pediatr Adolesc Gynecol. 2009 Feb;22(1):11-8
pubmed: 19232297
Res Microbiol. 2017 Nov - Dec;168(9-10):782-792
pubmed: 28435139
J Adolesc Health. 2011 Jul;49(1):42-6
pubmed: 21700155
J Clin Microbiol. 1991 Feb;29(2):297-301
pubmed: 1706728
Obstet Gynecol. 2000 Sep;96(3):431-9
pubmed: 10960638
Curr Opin Obstet Gynecol. 2006 Oct;18(5):503-10
pubmed: 16932044
Immunity. 2017 Jan 17;46(1):29-37
pubmed: 28087240
J Immunol Methods. 2011 Mar 31;367(1-2):47-55
pubmed: 21324321
Lancet Infect Dis. 2012 Jan;12(1):19-26
pubmed: 21975269
J Pediatr. 2002 Nov;141(5):718-23
pubmed: 12410205
J Reprod Immunol. 2011 Jan;88(1):66-71
pubmed: 21051089
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7
pubmed: 20534435
Lancet Infect Dis. 2016 Apr;16(4):441-8
pubmed: 26723758
Science. 2017 Jun 2;356(6341):938-945
pubmed: 28572388
Trends Immunol. 2001 Nov;22(11):626-33
pubmed: 11698224
Nat Methods. 2013 Dec;10(12):1200-2
pubmed: 24076764
mBio. 2015 Oct 06;6(5):e01084-15
pubmed: 26443453
Virology. 2016 Jun;493:247-54
pubmed: 27065342
Endocr Rev. 2007 Aug;28(5):521-74
pubmed: 17640948
Br J Obstet Gynaecol. 1998 Oct;105(10):1082-90
pubmed: 9800931
Immunity. 2015 May 19;42(5):965-76
pubmed: 25992865
ISME J. 2014 Sep;8(9):1781-93
pubmed: 24599071
Sex Transm Infect. 2016 May;92(3):186-93
pubmed: 26511781
J Infect Dis. 2005 Feb 1;191(3):358-66
pubmed: 15633094
Immunology. 2017 Aug;151(4):464-473
pubmed: 28398593
Mucosal Immunol. 2011 Mar;4(2):208-16
pubmed: 20844481
Int J STD AIDS. 2018 May;29(6):531-539
pubmed: 29198180
Infect Immun. 2017 Dec 19;86(1):
pubmed: 29038128
Maturitas. 2003 Dec 10;46 Suppl 1:S7-S16
pubmed: 14670641
PLoS One. 2017 Jun 7;12(6):e0178884
pubmed: 28591132
FEMS Microbiol Rev. 2013 Sep;37(5):762-92
pubmed: 23789590
Microbes Infect. 2003 Jan;5(1):59-67
pubmed: 12593974
Am J Med. 1983 Jan;74(1):14-22
pubmed: 6600371
J Infect Dis. 2011 Nov 15;204(10):1550-6
pubmed: 21940422
Am J Reprod Immunol. 2013 Feb;69 Suppl 1:27-40
pubmed: 23176109
J Infect Dis. 2014 Jun 15;209(12):1989-99
pubmed: 24403560

Auteurs

Smritee Dabee (S)

Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
DST-NRF CAPRISA Centre of Excellence in HIV Prevention, Durban, South Africa.

Shaun L Barnabas (SL)

Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Desmond Tutu HIV Foundation (DTHF), University of Cape Town, Cape Town, South Africa.

Katie S Lennard (KS)

Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.

Shameem Z Jaumdally (SZ)

Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
DST-NRF CAPRISA Centre of Excellence in HIV Prevention, Durban, South Africa.

Hoyam Gamieldien (H)

Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.

Christina Balle (C)

Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.

Anna-Ursula Happel (AU)

Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
DST-NRF CAPRISA Centre of Excellence in HIV Prevention, Durban, South Africa.

Brandon D Murugan (BD)

Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.

Anna-Lise Williamson (AL)

Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
SAMRC-UCT Gynaecological Cancer Research Center (GCRC), University of Cape Town, Cape Town, South Africa.
National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.

Nonhlanhla Mkhize (N)

Centre for HIV and STIs, National Institute for Communicable Disease (NICD), National Health Laboratory Service, Johannesburg, South Africa.

Janan Dietrich (J)

Perinatal HIV Research Unit (PHRU), Faculty of Health Sciences, University of the Witwatersrand, Diepkloof, Johannesburg, South Africa.

David A Lewis (DA)

Western Sydney Sexual Health Centre, Western Sydney Local Health District, Parramatta, Australia.
Marie Bashir Institute for Infectious Diseases and Biosecurity & Sydney Medical School-Westmead, University of Sydney, Sydney, Australia.

Francesca Chiodi (F)

Karolinska Institute, Stockholm, Sweden.

Thomas J Hope (TJ)

Northwestern University, Chicago, IL, United States of America.

Robin Shattock (R)

Imperial College London, London, United Kingdom.

Glenda Gray (G)

Perinatal HIV Research Unit (PHRU), Faculty of Health Sciences, University of the Witwatersrand, Diepkloof, Johannesburg, South Africa.
South African Medical Research Council, Cape Town, South Africa.

Linda-Gail Bekker (LG)

Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Desmond Tutu HIV Foundation (DTHF), University of Cape Town, Cape Town, South Africa.

Heather B Jaspan (HB)

Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Seattle Children's Research Institute, University of Washington, Seattle, Washington, United States of America.

Jo-Ann S Passmore (JS)

Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
DST-NRF CAPRISA Centre of Excellence in HIV Prevention, Durban, South Africa.
SAMRC-UCT Gynaecological Cancer Research Center (GCRC), University of Cape Town, Cape Town, South Africa.
National Health Laboratory Service, Groote Schuur Hospital, Cape Town, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH